Audit Report

Mallinckrodt Pharmaceuticals JA – 767

Audit #: JA - 767
Region: United States
Material: API/Excipients
Company: Mallinckrodt Pharmaceuticals
Location: 8801 Capital Boulevard Raleigh NC 27616
Date: 19 September 2017

This Rx-360 Audit Report contains the following scope:

The scope of the audit is to assess the quality management system using the Rx-360 Audit
Standards for Active Pharmaceutical Ingredients such as Paracetamol (EP), Acetaminophen,
USP, Acetaminophen USP 404 kg, Acetaminophen USP 100 kg & Acetaminophen USP